SUBSCRIBE
SUBSCRIBE
News   Business

Oxygen Biotherapeutics, Inc. Names New Chief Financial Officer

September 25, 2008 | 
1 min read
COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced the appointment of Charles H. Seeman as the company’s chief financial officer and executive vice president finance and administration.
People
Tenax Therapeutics
MORE ON THIS TOPIC
Tourist camp with fire, tent and firewood
Series A
New biotech cAMPfield emerges with $180M to reshape IBD treatment
June 18, 2026
 · 
2 min read
 · 
Gabrielle Masson
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Cardio biotech Kardigan binds off $400M upsized IPO
June 18, 2026
 · 
16 min read
 · 
Editorial Team
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
June 18, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration showing candidate resume being reviewed by employer
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
June 18, 2026
 · 
4 min read
 · 
Angela Gabriel